SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

MPS Pharmaa - Quaterly Results

12 Feb 2025 Evaluate
The revenue for the December 2024 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2024 is Rs. -1.75 millions as compared to Net Loss of Rs. -2.15 millions of corresponding quarter ended December 2023 Operating profit Margin for the quarter ended December 2024 improved to -1.41% as compared to -1.84% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.44 0.00 0.00 0.48 0.92 -47.83 0.94 0.23 308.70
PBIDT -1.41 -1.84 -23.37 -5.25 -4.95 6.06 -7.05 -9.25 -23.78
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00
PBDT -1.41 -1.84 -23.37 -5.25 -4.95 6.06 -7.06 -9.26 -23.76
Depreciation 0.37 0.37 0.00 1.11 1.11 0.00 1.47 1.46 0.68
PBT -1.78 -2.21 -19.46 -6.36 -6.06 4.95 -8.53 -10.72 -20.43
TAX -0.03 -0.06 -50.00 -0.16 -0.18 -11.11 -0.22 -0.21 4.76
Deferred Tax -0.03 -0.06 -50.00 -0.16 -0.18 -11.11 -0.22 -0.21 4.76
PAT -1.75 -2.15 -18.60 -6.20 -5.88 5.44 -8.31 -10.51 -20.93
Equity 191.11 191.11 0.00 191.11 191.11 0.00 191.11 191.11 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

MPS Pharmaa Share Price

1.73 0.00 (0.00%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.30
Dr. Reddys Lab 1237.90
Cipla 1238.95
Zydus Lifesciences 941.85
Lupin 2332.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×